SCHEMBL4024489

SCHEMBL4024489

Cc1cc(-c2ccc(F)cc2)cc(C)c1Cc1[nH]nc2c1C[C@H](N1CCCC1=O)CC2

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 5/20 0.35
MCHR1 Q99705 3/20 0.34
CTSS P25774 2/20 0.32
CYP2D6 P10635 1/20 0.32
HRH1 P35367 1/20 0.32
DRD2 P14416 2/20 0.32
HTR2A P28223 2/20 0.32
RORC P51449 2/20 0.32
KDM5A P29375 1/20 0.32
KCNH2 Q12809 1/20 0.31
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
PARP1 P09874 1/20 0.31
EED O75530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030735 0.90 NPY5R (0.35) NPY5RMCHR1CTSSCYP2D6HRH1
SCHEMBL4029262 0.90 NPY5R (0.35) NPY5RMCHR1CTSSCYP2D6HRH1
SCHEMBL4024067 0.90 NPY5R (0.35) NPY5RMCHR1CTSSCYP2D6HRH1
SCHEMBL4028410 0.85 KDM5A (0.36) KDM5AEED
SCHEMBL4024182 0.80 LTA4H (0.34) MCHR1CTSSCYP2D6HRH1RORC
SCHEMBL4024463 0.80 BRD4 (0.37) MCHR1CYP2D6RORCKCNH2
SCHEMBL4031855 0.76 KDM5A (0.34) KDM5A
SCHEMBL4025157 0.76 KDM5A (0.34) KDM5A
SCHEMBL4023855 0.76 KDM5A (0.34) KDM5A
SCHEMBL4024429 0.76 OPRL1 (0.35) HTR2AKDM5AKCNH2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029579-A2 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2009-03-04 EP disclosed
WO-2007124254-A2 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed